Immutep
IMMP
$2.59
Share price
3.19%
Change (1 day)
58.90%
Change (1 year)
Categories
Revenue for Immutep (IMMP)
Revenue in 2017 (TTM): -$0.01 M
According to Immutep's latest financial reports the company's current revenue (TTM) is -$0.01 M. In 2023 the company made a revenue of N/A a decrease over the years 2022 revenue that were of $0.11 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immutep from 2008 to 2017
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | $0.11 M | |
| 2021 | N/A | -100% |
| 2020 | $5.14 M | 5140.34% |
| 2019 | $0.09 M | -94.96% |
| 2018 | $1.94 M | |
| 2017 | N/A | -100% |
| 2016 | $0.13 M | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | $0.04 M | 74.56% |
| 2009 | $0.02 M | |
| 2008 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $4.50 B | -1,620,143,984.89% | 🇺🇸 USA |
 FibroGen FGEN | $0.14 B | -53,148,301.44% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $6.21 M | -2,235,451.08% | 🇺🇸 USA |